Ibogaine Clinic and Research Center Ensure Safety Protocol of Ibogaine Hydrochloride.

MIAMI, FL / ACCESSWIRE / September 28, 2023 / Located in Playa Del Carmen, Mexico, David Dardashti owns and operates an ibogaine clinic that both offers treatment to those struggling with addiction and mental health, and also conducts regular research used to conduct the most optimal protocols to ensure the most effective treatment possible. The clinic’s current research ensures optimal dosing of ibogaine hydrochloride on a physiological level. How is this done?

To ensure safety precautions of ibogaine hydrochloride the clinic has conducted an experiment based on the authorisation of twenty different people receiving ibogaine treatment. Blood was drawn prior to treatment and measured once more in the days after treatment. This was essential to properly analyze all vital bioavailability factors.

The research indicated a healthy distribution of biological factors such as various blood cells, blood sugar, insulin, and even testosterone. The test not only demonstrated that ibogaine did not disrupt any biological functionality it also showed stabilization of such entities .Those who displayed low numbers of biological entities tended to see a healthy increase and those with high numbers of biological entities tended to see an increase. This study helped prove ibogaine to not only be safe on a physiological level, it demonstrated its medicinal properties.

The ibogaine clinic is in the process of creating a detailed analysis of the report based on doctor approved authorization. This will allow those concerned about the safety protocol of ibogaine proven results to ensure a healthy and successful treatment. The clinic continues to measure success by enhancing more effective protocol. The ibogaine dosage is essential for the most optimal treatment. By combining these lab approved results the facility extends its research in order and expands its horizons.

For more information about DR. Ashok J. Bharucha, MD, please visit his credentials at

https://docs.google.com/document/d/1JC_V4qKvWBGvBm7H2lRE0olqdHex01iT/edit?usp=sharing&ouid=104855725655878546082&rtpof=true&sd=true

News Source: PinionNewswire

Media Contacts:
Gavriel Dardashti
gavriel@ibogaineclinic.com

SOURCE: IBOGAINE

View source version on accesswire.com:
https://www.accesswire.com/788530/ibogaine-clinic-and-research-center-ensure-safety-protocol-of-ibogaine-hydrochloride

Staff

Recent Posts

Hemogenyx Pharmaceuticals PLC Announces IRB Approval for Phase I Clinical Trial

Hemogenyx Pharmaceuticals Receives IRB Approval for Phase 1 Clinical Trial of HEMO-CAR-T (HG-CT-1)LONDON, UK /…

5 hours ago

Modular Medical Announces Pricing of $8.2 Million Public Offering

SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular…

8 hours ago

Nicole Garrett and Under Pressure Hyperbarics Lead the Charge in Wellness Education With Immersive Events at L.A. Fashion Weekend and Beyond

BEVERLY HILLS, CALIFORNIA / ACCESSWIRE / November 21, 2024 / Nicole Garrett, CEO of Under…

11 hours ago

Beacon Healthcare Systems Expands Leadership Team with Addition of Ayman Mohamed as Chief Technology Officer

HUNTINGTON BEACH, Calif., Nov. 21, 2024 /PRNewswire/ -- Beacon Healthcare Systems, is pleased to announce…

14 hours ago

Talkiatry Ranked Number 6 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Attributes Revenue Growth to Innovative Partnerships, Strong Team, and Unique Value-Based Care Model NEW YORK,…

14 hours ago

Bright Light Imaging Leverages Alpha Nodus’s Gravity Auth, Enhanced by Integration with ADS’s MedicsRIS, to Streamline Patient Care

Automation That Makes a Difference SUNRISE, Fla., Nov. 21, 2024 /PRNewswire/ -- When it comes…

14 hours ago